Merck

4. Merck

Total Ad Spend: $285.5 million
Television: $133.7 million
Magazine: $87.8 million
Other: $64 million

After resolving the manufacturing and supply problems that constricted supplies of Zostavax for several years, Merck ($MRK) decided on a disease-awareness campaign to herald its revival in the market. The campaign must have worked, because Zostavax was one of the best-selling vaccines last year.


In the spotlight

Shingles awareness, $46.7 million
Nasonex, $46.3 million
Zostavax, $46 million


 

Merck
Read more on

Suggested Articles

AbbVie
Pharma

AbbVie's Rinvoq label portends safety warnings for future JAKs

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.

by Carly Helfand
Novartis CEO Vas Narasimhan 2019
Pharma

Novartis CEO (sort of) admits mishandling Zolgensma crisis

Rather than "we did the best we could," Vas Narasimhan, during an internal call with managers, said Novartis could have handled the Zolgensma crisis…

by Angus Liu
Manufacturing

Sun's future brightens with FDA plant upgrade and China deal 

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.

by Eric Palmer